We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Analysis Compared for Accurate Pleural Fluid pH Determination

By LabMedica International staff writers
Posted on 12 Mar 2019
Print article
Image: The pHOx Ultra blood gas analyzer is used for routine blood gas analysis (Photo courtesy of Nova Biomedical).
Image: The pHOx Ultra blood gas analyzer is used for routine blood gas analysis (Photo courtesy of Nova Biomedical).
Pleural effusion is the pathological accumulation of pleural fluid resulting from excess fluid production and/or increased transpleural pressure, increased capillary permeability, and impaired lymphatic drainage.

Pleural effusion occurs in many pulmonary or systemic diseases such as infection, liver cirrhosis, congestive heart failure, and malignancy. For assessment and differential diagnosis of the cause of pleural effusion, pleural fluid pH is one of the most useful indicators, along with the widely recommended indicators such as total protein, lactate dehydrogenase, and glucose levels.

Medical Laboratory Scientists at the Yonsei University College of Medicine (Seoul, Republic of Korea) evaluated from in- and out-patient samples obtained from thoracentesis or pigtail catheter drainage and submitted to the laboratory for routine body fluid analysis. The Clot Catcher, a disposable and single-use device designed to filter off microclots or debris, was inserted between the syringe and the blood gas analyzer.

The i-STAT G3+, a cartridge-based blood gas analyzer, was used as a reference analyzer for comparison with the other three methods. The i-Smart 300, a recently introduced cartridge-based blood gas analyzer, was evaluated for comparison. The Nova Biomedical pHOx Ultra now in use for routine arterial blood gas analysis in their laboratory, and pH indicator paper was also compared.

The scientists reported that the within-device precision of all three blood gas analyzers was acceptable within 0.1% according to the desirable precision criteria. For the i-STAT G3+, within-device CV(%) at low (pH 7.04) and high levels (pH 7.76) was 0.05% and 0.04%, respectively. For the pHOx Ultra, total CV(%) was 0.03% for all levels (pH 7.13, 7.35, and 7.59). For the i-Smart 300, total CV(%) at low, mid, and high levels (pH 7.13, 7.36 and 7.59, respectively) was 0.09%, 0.08%, and 0.09%, respectively.

The i-Smart 300 showed good agreement with i-STAT G3+, with a slope of 0.85 (95% CI, 0.800–0.906). The pHOx Ultra showed about 30% lower pH values than the i-STAT G3+. The slope of equation for pH indicator paper was 1.105, with a relatively wide range of 95% CI (0.781−1.581).

The authors concluded that pleural fluid pH determination using both blood gas analyzers, the i-Smart 300 and pHOx Ultra, is sufficiently accurate for diagnosing complicated parapneumonic effusion (CPPE), if pleural fluid is collected anaerobically in a heparinized syringe and a Clot Catcher is used to protect blood gas analyzers. The study was published on January 29, 2019, in the journal Practical Laboratory Medicine.

Related Links:
Yonsei University College of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more